Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 4/2002

01-12-2002 | Case Report

Poorly differentiated oxyphilic (Hürthle cell) carcinoma arising in lingual thyroid: A case report and review of the literature

Authors: Juan Manuel Seoane, MD, PhD, Dr. José Cameselle-Teijeiro, MD, PhD, María Amparo Romero, MD, PhD

Published in: Endocrine Pathology | Issue 4/2002

Login to get access
Metadata
Title
Poorly differentiated oxyphilic (Hürthle cell) carcinoma arising in lingual thyroid: A case report and review of the literature
Authors
Juan Manuel Seoane, MD, PhD
Dr. José Cameselle-Teijeiro, MD, PhD
María Amparo Romero, MD, PhD
Publication date
01-12-2002
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 4/2002
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1385/EP:13:4:353

Other articles of this Issue 4/2002

Endocrine Pathology 4/2002 Go to the issue

Clinical Research

An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes

Clinical Research

Tumors of thyroid follicular epithelium: Where have we been and where are we going?

Clinical Research

Follicular, papillary, and “Hybrid” carcinomas of the thyroid

Clinical Research

Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies

Clinical Research

Etiology and significance of the “optically clear nucleus”

Clinical Research

Molecular pathobiology of thyroid neoplasms
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits